HRTX logo

HRTX
Heron Therapeutics Inc

7,347
Mkt Cap
$224.48M
Volume
1.06M
52W High
$2.61
52W Low
$0.7362
PE Ratio
-9.96
HRTX Fundamentals
Price
$1.20
Prev Close
$1.19
Open
$1.20
50D MA
$0.9717
Beta
1.46
Avg. Volume
2.06M
EPS (Annual)
-$0.1211
P/B
17.01
Rev/Employee
$1.21M
$311.78
Loading...
Loading...
News
all
press releases
Heron Therapeutics (HRTX) Expected to Announce Quarterly Earnings on Tuesday
Heron Therapeutics (NASDAQ:HRTX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Brokerages
Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report) have earned a consensus recommendation of "Hold" from the five analysts that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a b...
MarketBeat·3d ago
News Placeholder
Research Analysts Set Expectations for HRTX Q1 Earnings
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - HC Wainwright dropped their Q1 2026 earnings estimates for shares of Heron Therapeutics in a report released on Thursday, April 23rd. HC...
MarketBeat·4d ago
News Placeholder
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Zacks·24d ago
News Placeholder
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Analysts
Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report) have received a consensus rating of "Hold" from the five research firms that are covering the firm, MarketBeat Ratings reports. One...
MarketBeat·28d ago
News Placeholder
Q1 Earnings Forecast for HRTX Issued By Northland Securities
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Northland Securities cut their Q1 2026 EPS estimates for Heron Therapeutics in a research note issued to investors on Thursday, March 26th...
MarketBeat·1mo ago
News Placeholder
What is Northland Securities' Estimate for HRTX Q3 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at Northland Securities upped their Q3 2026 earnings estimates for shares of Heron Therapeutics in a research note...
MarketBeat·1mo ago
News Placeholder
Baker BROS. Advisors LP Purchases New Position in Heron Therapeutics, Inc. $HRTX
Baker BROS. Advisors LP purchased a new stake in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·2mo ago
News Placeholder
Citigroup Inc. Increases Stock Position in Heron Therapeutics, Inc. $HRTX
Citigroup Inc. boosted its position in Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 4,666.9% during the third quarter, according to the company in its most recent filing with the...
MarketBeat·2mo ago
News Placeholder
HC Wainwright Has Negative Forecast for HRTX FY2026 Earnings
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at HC Wainwright reduced their FY2026 earnings per share (EPS) estimates for Heron Therapeutics in a research note...
MarketBeat·2mo ago
<
1
2
...
>

Latest HRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.